Accomplished leader with over a decade of experience in direct reporting, matrix, and project leadership roles within the pharmaceutical industry. Specializing in Regulatory Affairs, successfully leading diverse functions and regions, while contributing to Operations, Quality, Business Development, M&A, and Product Development. Earned a Doctorate Degree in 2018, focusing on leveraging digital technologies to enhance pharmaceutical companies' competitive edge. Active member of the Harvard Business School expert circle and the Harvard Business Review Advisory Council, engaging in discussions on new products, attending leadership events, and providing insights on industry trends such as AI solutions for improved sales and customer satisfaction. Strategic contributions to regulatory compliance, commercial operations, and successful digital solutions implementation like Veeva Vault. Led significant work-streams in spin-offs of Pfizer Animal Health and establishing Zoetis, Bayer Animal Health spin off & acquisition & integration in Elanco, and spon off Sandoz from Novartis.
Leadership
Harvard Advisory Council